CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 200 filers reported holding CHEMOCENTRYX INC in Q4 2020. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $118,000 | -44.3% | 2,292 | -40.7% | 0.01% | -57.1% |
Q3 2020 | $212,000 | -7.0% | 3,867 | -2.9% | 0.01% | -6.7% |
Q2 2020 | $228,000 | +128.0% | 3,981 | +61.0% | 0.02% | +87.5% |
Q1 2020 | $100,000 | +455.6% | 2,473 | +430.7% | 0.01% | +700.0% |
Q4 2019 | $18,000 | -57.1% | 466 | -89.7% | 0.00% | -66.7% |
Q2 2019 | $42,000 | -51.2% | 4,543 | -26.4% | 0.00% | -57.1% |
Q1 2019 | $86,000 | +168.8% | 6,176 | +103.5% | 0.01% | +133.3% |
Q4 2018 | $32,000 | -20.0% | 3,035 | -2.7% | 0.00% | 0.0% |
Q3 2018 | $40,000 | -100.0% | 3,118 | -53.1% | 0.00% | -62.5% |
Q2 2018 | $87,621,000 | +973466.7% | 6,653 | +944.4% | 0.01% | +700.0% |
Q1 2018 | $9,000 | +125.0% | 637 | -11.0% | 0.00% | – |
Q4 2017 | $4,000 | +300.0% | 716 | +383.8% | 0.00% | – |
Q3 2017 | $1,000 | 0.0% | 148 | 0.0% | 0.00% | – |
Q2 2017 | $1,000 | -83.3% | 148 | -83.8% | 0.00% | -100.0% |
Q1 2017 | $6,000 | -14.3% | 916 | +2.8% | 0.00% | 0.0% |
Q4 2016 | $7,000 | – | 891 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |